F. Frank Kadlubar

F. Frank Kadlubar's AcademicInfluence.com Rankings

F. Frank Kadlubar

Medical

#2078

World Rank

#2476

Historical Rank

Pharmacology

#217

World Rank

#257

Historical Rank

medical Degrees

Download Badge

Medical

F. Frank Kadlubar's Degrees

PhD Pharmacology University of Arkansas for Medical Sciences
Bachelors Pharmacy University of Arkansas for Medical Sciences

Why Is F. Frank Kadlubar Influential?

(Suggest an Edit or Addition)

(See a Problem?)

F. Frank Kadlubar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. (1989) (668)
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. (1992) (421)
Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. (1994) (421)
Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. (1991) (358)
Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. (1993) (330)
Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. (1977) (320)
Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients (2005) (317)
Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens (1994) (275)
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. (2002) (261)
Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. (1995) (250)
N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. (1992) (250)
Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. (1995) (240)
Metabolic Activation and DNA Adducts of Aromatic Amines and Nitroaromatic Hydrocarbons (1990) (236)
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. (2005) (235)
The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. (1992) (235)
Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. (1992) (231)
Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. (2001) (219)
Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. (1998) (216)
Role of aromatic amine acetyltransferase in human colorectal cancer. (1986) (207)
Detoxification of electrophilic compounds by glutathione S‐transferase catalysis: Determinants of individual response to chemical carcinogens and chemotherapeutic drugs? (2003) (202)
Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans. (1994) (196)
Human cytochrome P4501A2. (1999) (192)
Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. (2001) (191)
Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. (1983) (190)
Formation and persistence of arylamine DNA adducts in vivo. (1985) (188)
Increased transcriptional activity of the CYP3A4*1B promoter variant (2003) (185)
Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis (1983) (183)
Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. (2000) (173)
Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay. (1986) (170)
Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. (1998) (169)
Carcinogen substrate specificity of human COX-1 and COX-2. (2001) (168)
Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. (1989) (166)
In Situ Hybridization and Immunohistochemical Analysis of Cytochrome P450 1B1 Expression in Human Normal Tissues (2001) (166)
Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. (2002) (166)
Microsomal-catalyzed hydroperoxide-dependent C-oxidation of amines. (1973) (164)
Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. (2005) (159)
Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. (1994) (156)
Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. (1985) (154)
Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). (1995) (153)
Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism. (2000) (152)
Meat intake and cooking techniques: associations with pancreatic cancer. (2002) (152)
Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. (1994) (150)
Identification of N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. (1992) (147)
Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. (2002) (140)
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. (1994) (140)
Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. (1985) (139)
Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters. (1976) (136)
Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. (1997) (136)
Structural and conformational analyses of 8-hydroxy-2'-deoxyguanosine. (1989) (132)
Identification of aminobiphenyl derivatives in commercial hair dyes. (2003) (129)
Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32P-postlabeling. (1994) (129)
Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. (1992) (127)
Chemical Properties of Ultimate Carcinogenic Metabolites of Arylamines and Arylamides (1985) (126)
Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population (2001) (124)
Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. (1999) (123)
Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. (1999) (121)
Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. (2000) (119)
Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA. (1982) (118)
Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. (2006) (117)
Associations between Catalase Phenotype and Genotype: Modification by Epidemiologic Factors (2006) (114)
The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. (2003) (114)
Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene. (1976) (114)
Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. (2002) (111)
Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. (2002) (110)
Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men (2006) (109)
Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. (1997) (109)
Comparison of DNA adduct levels associated with oxidative stress in human pancreas. (1998) (108)
Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. (1999) (108)
Guanyl O6-arylamination and O6-arylation of DNA by the carcinogen N-hydroxy-1-naphthylamine. (1978) (104)
The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. (2001) (103)
Mechanism of C8 alkylation of guanine residues by activated arylamines: evidence for initial adduct formation at the N7 position. (1992) (100)
Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. (1982) (99)
Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype (2006) (98)
Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. (1998) (97)
Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals. (2002) (97)
Dietary Intake of Heterocyclic Amines and Benzo(a)Pyrene: Associations with Pancreatic Cancer (2005) (97)
Metabolic activation of aromatic amines by human pancreas. (1997) (96)
Association between a glutathione S‐transferase A1 promoter polymorphism and survival after breast cancer treatment (2003) (94)
Aromatic amine acetyltransferase as a marker for colorectal cancer: Environmental and demographic associations (1990) (94)
In vitro reaction of the carcinogen, N-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenine. (1980) (93)
Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. (1984) (93)
DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair (2007) (93)
Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse. (1992) (93)
Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. (2000) (91)
Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. (2001) (91)
Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa. (1996) (90)
32P Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. (1991) (90)
Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. (2000) (88)
Alkyl and aryl carcinogen adducts detected in human peripheral lung. (1989) (87)
Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. (1991) (86)
Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. (1994) (86)
Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. (1981) (86)
Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells (2008) (86)
Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. (1997) (84)
Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans. (1994) (84)
Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases. (1986) (82)
Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. (1982) (82)
Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. (1989) (81)
Activation of 2‐Hydroxyamino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridne by cDNA‐expressed Human and Rat Arylsulfotransferases (1994) (81)
Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. (1995) (80)
Formation and identification of glutathione conjugates from 2-nitrosofluorene and N-hydroxy-2-aminofluorene. (1982) (80)
A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols. (2000) (76)
Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. (1994) (76)
Reduced pyridine nucleotide-dependent N-hydroxy amine oxidase and reductase activities of hepatic microsomes. (1973) (76)
Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. (2003) (76)
DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. (1985) (75)
CYP2A13 expressed in human bladder metabolically activates 4‐aminobiphenyl (2006) (75)
Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. (2003) (74)
CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice. (1999) (71)
Characterization of DNA adducts of the carcinogen N-methyl-4-aminoazobenzene in vitro and in vivo. (1980) (71)
Physical Activity, Diet, and Pancreatic Cancer: A Population-Based, Case-Control Study in Minnesota (2009) (71)
Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases. (1995) (70)
Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay. (1997) (70)
Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. (1998) (69)
Expression of monomorphic and polymorphic N-acetyltransferases in human colon. (1994) (69)
Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomes. (1974) (68)
An FDA review of sulfamethazine toxicity. (1999) (67)
Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. (1988) (66)
Metabolic activation and carcinogen-DNA adduct detection in human larynx. (1994) (66)
Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. (2010) (65)
Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. (2010) (65)
The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. (2007) (65)
Role of acetylation in colorectal cancer. (1993) (65)
Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. (1995) (65)
Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. (2010) (65)
Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2. (1997) (64)
Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians (2004) (64)
Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. (1994) (64)
Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form. (2004) (63)
Metabolism of the mutagenic environmental pollutant, 6-nitrobenzo[a]pyrene: metabolic activation via ring oxidation. (1982) (62)
Processed meat intake, CYP2A6 activity and risk of colorectal adenoma. (2007) (61)
Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines. (2004) (61)
Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. (2007) (59)
Characterization of the purine ring-opened 7-methylguanine and its persistence in rat bladder epithelial DNA after treatment with the carcinogen N-methylnitrosourea. (1984) (59)
Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes. (2001) (58)
Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1. (1999) (58)
SNPs, haplotypes, and cancer: applications in molecular epidemiology. (2004) (58)
Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2. (1996) (58)
Nitrogen-15 nuclear magnetic resonance studies on the tautomerism of 8-hydroxy-2'-deoxyguanosine, 8-hydroxyguanosine, and other C8-substituted guanine nucleosides (1990) (57)
In vitro bioactivation of N-hydroxy-2-amino-α-carboline (2000) (57)
Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype. (2000) (55)
Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. (1996) (55)
Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method. (1999) (54)
Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility. (1996) (53)
Specific site methylation in the 5'-flanking region of CYP1A2 interindividual differences in human livers. (2001) (53)
A new clue to glaucoma pathogenesis. (2003) (53)
DNA adducts of carcinogenic aromatic amines. (1994) (53)
Formation of urothelial and hepatic DNA adducts from carcinogen 2-naphthylamine. (1981) (53)
DNA adducts formed from the probable proximate carcinogen, N-hydroxy-3,2' -dimethyl-4-aminobiphenyl, by acid catalysis or S-acetyl coenzyme A-dependent enzymatic esterification. (1985) (52)
Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative. (1999) (52)
Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. (1986) (52)
Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer. (2002) (52)
Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology. (1992) (50)
NAT2 slow acetylation and bladder cancer in workers exposed to benzidine (2006) (49)
Sulfating-activity and stability of cDNA-expressed allozymes of human phenol sulfotransferase, ST1A3*1 ((213)Arg) and ST1A3*2 ((213)His), both of which exist in Japanese as well as Caucasians. (1999) (49)
Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N‐acetyltransferase and glutathione S‐transferase activities (2004) (49)
Identification of C8-modified deoxyinosine and N2- and C8-modified deoxyguanosine as major products of the in vitro reaction of N-hydroxy-6-aminochrysene with DNA and the formation of these adducts in isolated rat hepatocytes treated with 6-nitrochrysene and 6-aminochrysene. (1987) (48)
Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. (2005) (47)
CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. (2002) (47)
Plasma Carotenoids and Prostate Cancer: A Population-Based Case-Control Study in Arkansas (2006) (46)
Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. (2003) (46)
Roles of human hepatic and pulmonary cytochrome P450 enzymes in the metabolism of the environmental carcinogen 6-nitrochrysene. (1993) (45)
Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. (2003) (45)
Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis. (1995) (44)
Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes. (1999) (44)
Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. (1995) (43)
Transformation of normal human skin fibroblasts by 1-nitropyrene and 6-nitrobenzo[a]pyrene. (1983) (42)
Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. (1985) (42)
Binding of N-acetylbenzidine and N,N'-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. (1984) (41)
Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases. (1999) (41)
Metabolic activation of N-hydroxy-N,N'-diacetylbenzidine by hepatic sulfotransferase. (1980) (41)
Toward an integrated approach to molecular epidemiology. (1997) (40)
The S-acetyl coenzyme A-dependent metabolic activation of the carcinogen N-hydroxy-2-aminofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype. (1987) (39)
Common genetic polymorphisms in the 5′-flanking Region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity (2005) (39)
Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. (1991) (39)
Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide. (2000) (39)
The effects of saccharin on the development of neoplastic lesions initiated with N-methyl-N-nitrosourea in the rat urothelium. (1986) (38)
Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity. (1995) (38)
Cystine-Glutamate Transporter SLC7A11 Mediates Resistance to Geldanamycin but Not to 17-(Allylamino)-17-demethoxygeldanamycin (2007) (38)
Applying new biotechnologies to the study of occupational cancer--a workshop summary. (2004) (37)
Increased expression of hepatic DNA methyltransferase in smokers (2004) (37)
Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype. (1999) (37)
Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites. (1990) (37)
Caloric restriction profoundly inhibits liver tumor formation after initiation by 6-nitrochrysene in male mice. (1994) (36)
Mitochondrial Mutagenesis and Oxidative Stress in Human Prostate Cancer (2004) (36)
Lack of association between Caucasian lung cancer risk and O6-methylguanine-DNA methyltransferase-codon 178 genetic polymorphism. (2004) (36)
Role of the microsomal mixed-function amine oxidase in the oxidation of N,N-disubstituted hydroxylamines. (1974) (35)
N-methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines. (1988) (35)
Mutagenicity of nitrofurans in Salmonella typhimurium TA98, TA98NR and TA98/1,8-DNP6. (1987) (35)
A transversion mutation hypothesis for chemical carcinogenesis by N2-substitution of guanine in DNA. (1980) (35)
Reaction of mutagenic phenacetin metabolites with glutathione and DNA. Possible implications for toxicity. (1984) (35)
Assessment of exposure and susceptibility to aromatic amine carcinogens. (1988) (35)
Formation of N-(glutathion-S-methylene)-4-aminoazobenzene following metabolic oxidation of the N-methyl group of the carcinogen, N-methyl-4-aminoazobenzene. (1982) (35)
HepaticMicrosomalN-Glucuronidationand NucleicAcid Binding of N-HydroxyArylaminesin Relationto Urinary Bladder Carcinogenesis1 (1977) (34)
Exfoliated ductal epithelial cells in human breast milk: a source of target tissue DNA for molecular epidemiologic studies of breast cancer. (1998) (34)
Specificity of mutagenesis by 4-aminobiphenyl. A possible role for N-(deoxyadenosin-8-yl)-4-aminobiphenyl as a premutational lesion. (1988) (33)
Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines. (2004) (32)
Carcinogen-DNA adduct formation in the lungs and livers of preweanling CD-1 male mice following administration of [3H]-6-nitrochrysene, [3H]-6-aminochrysene, and [3H]-1,6-dinitropyrene. (1987) (32)
Parallel between ultraviolet light and 4-nitroquinoline-1-oxide sensitivity in Bacillus subtilis (1968) (32)
CYP3A43 Pro340Ala Polymorphism and Prostate Cancer Risk in African Americans and Caucasians (2005) (32)
Quantitative immunohistochemical analysis of 4-aminobiphenyl-DNA in cultured cells and mice: comparison to gas chromatography/mass spectroscopy analysis. (1995) (31)
The metabolic N-oxidation of carcinogenic arylamines in relation to nitrogen charge density and oxidation potential. (1990) (30)
Metabolism of the carcinogen [3H]6-nitrochrysene in the preweanling mouse: identification of 6-aminochrysene-1,2-dihydrodiol as the probable proximate carcinogenic metabolite. (1988) (30)
Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis. (2010) (30)
Sequence variants in antioxidant defense and DNA repair genes, dietary antioxidants, and pancreatic cancer risk. (2011) (29)
A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer (2008) (28)
Formation of DNA adducts in vivo in rat liver and intestinal epithelium after administration of the carcinogen 3,2'-dimethyl-4-aminobiphenyl and its hydroxamic acid. (1985) (28)
In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline. (2000) (28)
The effects of phytoestrogens on human pancreatic tumor cells in vitro. (1999) (28)
2-ethynylnaphthalene as a mechanism-based inactivator of the cytochrome P-450 catalyzed N-oxidation of 2-naphthylamine. (1989) (28)
The N-hydroxy metabolites of N-methyl-4-aminoazobenzene and related dyes as proximate carcinogens in the rat and mouse. (1979) (27)
A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine. (2010) (27)
Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk (2010) (27)
Glutathione adducts of N-methyl-4-aminoazobenzene formed in vivo and by reaction of N-benzoyloxy-N-methyl-4-aminoazobenzene with glutathione. (1979) (27)
Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation. (1983) (27)
Carcinogenic aromatic amine metabolism and DNA adduct detection in humans. (1990) (26)
A Modified Host Cell Reactivation Assay to Measure DNA Repair Capacity for Removing 4-Aminobiphenyl Adducts: A Pilot Study of Bladder Cancer (2005) (26)
Phenotypic CYP2A6 variation and the risk of pancreatic cancer. (2009) (26)
15N nuclear magnetic resonance studies on the tautomerism of 8-hydroxy-2'-deoxyguanosine, 8-hydroxyguanosine, and other C8-substituted guanine nucleosides. (1990) (26)
A probe for the mutagenic activity of the carcinogen 4-aminobiphenyl: synthesis and characterization of an M13mp10 genome containing the major carcinogen-DNA adduct at a unique site. (1987) (26)
Variation in cyclooxygenase expression levels within the colorectum (2003) (25)
Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue. (2002) (25)
Activation of carcinogens by human liver cytochromes P-450. (1990) (24)
Racial differences in motor neuron disease (2014) (24)
A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption. (1982) (24)
Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues. (1995) (24)
Metabolic differences and their impact on human disease Sulfotransferase and colorectal cancer. (1997) (23)
Metabolism and disposition of benzidine in the dog. (1990) (23)
Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F(1) neonatal mouse. (2002) (22)
Metabolic activation of methyl-hydroxylated derivatives of 7,12-dimethylbenz[a]anthracene by human liver dehydroepiandrosterone-steroid sulfotransferase. (1998) (22)
Application of biomarkers to risk assessment. (1992) (22)
Rapid absorption, distribution, and excretion of carcinogenic N-hydroxy-arylamines after direct urethral instillation into the rat urinary bladder. (1981) (22)
Direct O-acetylation of N-hydroxy arylamines by acetylsalicylic acid to form carcinogen-DNA adducts. (1992) (22)
Examination of Human Tissue Cytosols for Expression of Sulfotransferase Isoform 1A2 (SULT1A2) Using a SULT1A2-Specific Antibody (2005) (20)
1998 International Meeting on the Arylamine N-Acetyltransferases: synopsis of the workshop on nomenclature, biochemistry, molecular biology, interspecies comparisons, and role in human disease risk. (1999) (20)
Formation and reactions of N(7)-aminoguanosine and derivatives. (1999) (20)
Mutagenicity of nitro-polycyclic aromatic hydrocarbons with the nitro substituent situated at the longest molecular axis. (1992) (20)
A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N-methyl-4-aminoazobenzene. (1981) (20)
Ultraperformance liquid chromatography-tandem mass spectrometry method for biomonitoring cooked meat carcinogens and their metabolites in human urine. (2011) (19)
Direct reduction of N-acetoxy-PhIP by tea polyphenols: a possible mechanism for chemoprevention against PhIP-DNA adduct formation. (2003) (19)
Specificity of mutagenesis by 4-aminobiphenyl: mutations at G residues in bacteriophage M13 DNA and G-->C transversions at a unique dG(8-ABP) lesion in single-stranded DNA. (1997) (19)
Sulfotransferase 4A1. (2008) (19)
Cancer Therapy and Polymorphisms of Cytochromes P450 (2000) (18)
Hepatic metabolism of chloral hydrate to free radical(s) and induction of lipid peroxidation. (1994) (18)
The CYP 3 A 4 * 1 B Variant Is Related to the Onset of Puberty , A Known Risk Factor for the Development of Breast Cancer 1 (2003) (17)
Gas chromatography-mass spectrometry analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and feces. (1993) (17)
Formation of 3-(glutathion-S-YL)-N-methyl-4-aminoazobenzene and inhibition of aminoazo dye-nucleic acid binding in vitro by reaction of glutathione with metabolically-generated N-methyl-4-aminoazobenzene-N-sulfate. (1980) (17)
Inducibility of human cytochromes P-450 primarily involved in the activation of chemical carcinogens (1992) (17)
Biologically active aromatic amines derived from carcinogenic polycyclic aromatic hydrocarbons: synthesis and mutagenicity of aminobenzo[a]pyrenes. (1982) (17)
Length of Deoxyribonucleic Acid of PBSX-like Particles of Bacillus subtilis Induced by 4-Nitroquinoline-1-Oxide (1969) (16)
A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers. (1991) (16)
Comparative direct-acting mutagenicity of 1- and 2-nitropyrene: evidence for 2-nitropyrene mutagenesis by both guanine and adenine adducts. (1991) (16)
Binding of benzidine, N-acetylbenzidine, N, N'-diacetylbenzidine and Direct Blue 6 to rat liver DNA. (1983) (16)
The effect of lifetime sodium saccharin dosing on mice initiated with the carcinogen 2-acetylaminofluorene. (1989) (16)
Metabolic activation of 6-nitrochrysene in explants of human bronchus and in isolated rat hepatocytes. (1989) (15)
Characterization and properties of the DNA adducts formed from N-methyl-4-aminoazobenzene in rats during a carcinogenic treatment regimen. (1987) (15)
Inhibitory effect of caloric restriction on tumorigenicity induced by 4-aminobiphenyl and 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) in the CD1 newborn mouse bioassay. (1996) (14)
Metabolic activation, DNA adducts, and H‐ras mutations in human neoplastic and non‐neoplastic laryngeal tissue (1993) (14)
Formation of malondialdehyde-modified 2'-deoxyguanosinyl adduct from metabolism of chloral hydrate by mouse liver microsomes. (1995) (14)
Characterization of 4,4'-methylenebis(2-chloroaniline)--DNA adducts formed in vivo and in vitro. (1992) (14)
Neonatal Mouse Tumorigenicity Bioassay* (1998) (13)
Metabolism and dna binding of carcinogenic aromatic amines (1987) (13)
Advantages and limitations of laboratory methods for measurement of carcinogen-DNA adducts for epidemiological studies. (1992) (12)
Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro. (1996) (12)
Carcinogen-DNA adduct formation as a predictor of metabolic activation pathways and reactive intermediates in benzidine carcinogenesis. (1986) (12)
Aromatic and heterocyclic amine metabolism and phenotyping in humans. (1991) (11)
Structural consequences of modification of the oxygen atom of guanine in DNA by the carcinogen N-hydroxy-1-naphthylamine. (1981) (10)
Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer. (2012) (10)
A chromatographic technique for the analysis of oxidized metabolites: application to carcinogenic N-hydroxyarylamines in urine. (1981) (10)
Detection of human DNA–carcinogen adducts (1992) (10)
Identification of 4'-sulphonyloxy-N-(glutathion-S-methylene)-4-aminoazobenzene, a compound conjugated with both sulphate and glutathione, which is a major biliary metabolite of N,N-dimethyl-4-aminoazobenzene. (1983) (10)
Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4, 5-f]quinoline. (2000) (10)
Study of sodium saccharin co-carcinogenicity in the rat. (1994) (10)
Sex differences in cytochrome P450 1B1, an estrogen-metabolizing enzyme, in the rhesus monkey telencephalon (2005) (9)
Enzymatic Basis of Phase I and Phase II Drug Metabolism (2010) (9)
Quantitation of the 32P-postlabeling reaction using cyclic N1,N2 and C8 modified deoxyguanosine 3'-monophosphates as substrates. (1991) (9)
Glutathione conjugate formation in the detoxification of ultimate and proximate carcinogens of N-methyl-4-aminoazobenzene. (1984) (7)
Correspondence re: letter to the editor by B. K. Tang and W. Kalow on CYP1A2 phenotyping using caffeine. Cancer Epidemiol. Biomarkers & Prev., 5: 231, 1996. (1996) (7)
Cocarcinogenicity of saccharin and N-alkylnitrosoureas in cultured human diploid fibroblasts. (1988) (7)
Effect of pH on the neoplastic transformation of normal human skin fibroblasts by N-hydroxy-1-naphthylamine and N-hydroxy-2-naphthylamine. (1981) (7)
Effect of Waterborne Potassium Permanganate Exposure on Manganese Content in Liver and Axial Muscle of Channel Catfish (1999) (7)
The binding of an aminoazo dye carcinogen to a specific methionine residue in rat liver alcohol dehydrogenase in vivo. (1987) (6)
Concluding remarks: symposium on Genetic Susceptibility to Environmental Toxicants. (2001) (5)
In Memoriam James A. Miller (1915−2000)1 (2001) (5)
Rethinking the role of intestinal microflora in bioactivation of food-borne heterocyclic amine carcinogens. (1994) (4)
Identification of the DNA adducts formed in vitro from N-benzoyloxy-N-methyl-4-aminoazobenzene and in rat liver in vivo after administration of N-methyl-4-aminoazobenzene. (1981) (4)
GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer (2013) (4)
Examination of Human Tissue Cytosols for Expression of Sulfotransferase Isoform 1 A 2 ( SULT 1 A 2 ) Using a SULT 1 A 2-Specific Antibody (2005) (4)
Commentary: Application of Biomarkers to Risk Assessment (1992) (4)
CANCER CHEMOPREVENTION FROM THE FOOD-BORNE CARCINOGEN 2-AMINO-1-METHYL-6-PHENYLIMIDAZO4,5-BPYRIDINE (1998) (3)
Estimates of the risk of bladder tumor promotion by saccharin in rats. (1988) (3)
Formation of DNA adducts by the carcinogen N-hydroxy-2-naphthylamine. (1981) (3)
[Direct detoxification of N-acetoxy-PhIP by tea polyphenols: a possible mechanism for chemoprevention against PhIP-DNA adduct formation in vivo]. (1998) (3)
Synthesis of N-(purin-8-yl)arylamines. (1993) (2)
Formation of a molecular epidemiology group? (1997) (2)
CYP2A6 Activity Determined by Caffeine Phenotyping (2002) (2)
Cytochromes P-450 as Determinants of Susceptibility to Carcinogenesis by Aromatic Amines and Nitroaromatic Hydrocarbons (1988) (1)
Uptake of 2-amino-1-methyl-6-phenylimidazo(4,5-b]pyridine (PhIP) and its N-hydroxy metabolite into rat pancreatic acini in vitro (1994) (1)
Reply to the letter to the Editor: “N‐Acetyltransferases and the susceptibility to benzidine‐induced bladder carcinogenesis” (2007) (1)
ATP-dependent kinase-catalyzed activation of N-hydroxy hetero-cyclic amines (2002) (1)
Carcinogen-DNA Adduct Formation in the Lungs and Livers of Preweanling CD-I Male Mice following Administration of [ 3 H ]-6-Nitrochrysene , [ 3 H ]-6-Aminochrysene , and [ 3 H ]-l , 6 - (2006) (1)
Abstract 1861: Polymorphisms in antioxidant defense and DNA repair genes, dietary intake of antioxidants, and risk of pancreatic cancer (2010) (1)
Detecting an association between prostate cancer occurrence and TCDD exposure in the U.S. Vietnam veteran population (2000) (1)
In memoriam: James A. Miller (1915-2000). (2001) (1)
Recent advances in biomarker research. Introduction. (1991) (1)
GSTM 1 copy number and promoter haplotype as predictors for risk of recurrence and / or second primary tumor in patients with head and neck cancer (2013) (1)
Molecular Epidemiology of Food Pyrolysis Products in Relation to Colon, Breast, and Prostate Cancer (2007) (0)
Acetylation of food-derived heterocyclic amine carcinogens by recombinant human monomorphic and polymorphic n-acetyltransferase (1992) (0)
大白菜抑制大鼠体内致癌物PhIP-DNA加合物形成及其可能的作用机理 (1998) (0)
Carcinogen-DN AAdduct si nHuma nBreast Epithelia lCells (2002) (0)
Gene-Environment Interactions (2020) (0)
THE STUDY ON CYP2A6 GENETIC POLYMORPHISM (1999) (0)
The N-HydroxyMetabolites of N-Methyl-4-aminoazobenzeneand Related Dyes as Proximate Carcinogensin the Rat and Mouse1 (1979) (0)
Use of polyclonal antibodies againstcarcinogen-DNA adducts and analysis (1998) (0)
Guanyl O6-Arylamination and O6-Arylation of DMA by the Carcinogen N-Hydroxy-1 (2006) (0)
Assessment of genotoxicity in humans exposed to carcinogenic aromatic amines and nitropolycylic aromatic hydrocarbons (1985) (0)
Introduction: Gene-Environmental Interactions in Molecular Epidemio- logy (2004) (0)
AROMATIC AMINES AND NITROAROMATIC HYDROCARBONS (1988) (0)
Abstract #5455: Interindividual variability in fulvestrant sulfation by human liver cytosols : effect of sult 1a1 genotype on fulvestrant sulfation (2009) (0)
绿茶抑制大鼠体内杂环胺-DNA加合物的形成 (1998) (0)
PATHWAYS AND REACTIVE INTERMEDIATES IN BENZIDINE CARCINOGENESIS (1986) (0)
Original Article Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer (2012) (0)
Quantitative Cancer Risk Assessment of Heterocyclic Amines in Cooked Foods (2018) (0)
Formation and Persistence of Arylamine (2016) (0)
Abstract B123: Sequence variants in inflammatory genes, plasma antioxidants, and prostate cancer risk (2010) (0)
The effects of sodium saccharin with and without N-methyl-N-nitrosourea co-treatment on anchorage-independent growth of human diploid fibroblasts. (1991) (0)
Cancer and Gene Variants in Enzymes Metabolizing Dietary Xenobiotics (2006) (0)
Reaction of Glutathione with 4-Nitrosobiphenyl (1990) (0)
DRUG METABOLISM : REGULATION AND IMPORTANCE SEPTEMBER 16-20 , 2001 , COPENHAGEN , DENMARK Organizing committee : (2011) (0)
Bladder and Kidney Prostaglandin H Synthase Metabolic Activation of Carcinogenic Aromatic Amines by Dog Updated (2006) (0)
Preface (1983) (0)
Molecular approaches to evaluation of the risk of aromatic amine-induced bladder cancer: smoking-related carcinogen—DNA adducts in biopsied samples of human urinary bladder (1991) (0)
Polymorphism Val 105-Transferase P 1 Ile S Cancer and Glutathione Association between Survival after Treatment for Breast (2000) (0)
Advances in Brief Polymorphism in the N .-Acetyltransferase 1 ( NATJ ) Polyadenylation Signal : Association of NAT 1 * 1 O Allele with Higher N-Acetylation Activity in Bladder and Colon Tissue (2006) (0)
A new approach for the quantification of mitochondrial DNA damage and repair in prostate cancer cells (2007) (0)
Copper accumulation in channel catfish (Ictalurus punctatus) exposed to water borne copper sulfate (1995) (0)
Research on gene polymorphism and ethnic differences of human CYP1A2. (1995) (0)
Two biological reactive intermediates in aminoazo-dye carcinogenesis and their glutathione adducts. (1981) (0)
Poster discussion: Carcinogenesis (1984) (0)
Cytochrome P-450-and Flavin-containing Monooxygenase-catalyzed Formation of the Carcinogen A /-Hydroxy-2-aminofluorene and Its Covalent Binding to Nuclear DMA 1 (2006) (0)
Cytochrome P-450- and Flavin-containing Monooxygenase-catalyzed Formation of the Carcinogen A/-Hydroxy-2-aminofluorene and Its Covalent Binding to Nuclear DMA1 (2006) (0)
Abstract 2619: Sulfation of toremifene: Individual variability, isoform specificity, and contribution to toremifene pharmacogenomics (2010) (0)
RE: "SEX DIFFERENCES IN RISK FACTORS FOR CLINICAL DIABETES MELLITUS IN A GENERAL POPULATION: A 12-YEAR FOLLOW-UP OF THE F1NNMARK STUDY" (1999) (0)
in Vitro and in Vivo the C-8 Atom of Deoxyguanosine-Acetylbenzidine to DNA at N Covalent Binding of Benzidine and Updated Version (2006) (0)
O I.2 Metabolic activation and detoxification of carcinogens in relation to DNA adduct levels and cancer susceptibility in humans (1997) (0)
Novel Recruitment Techniques for a Study of Culture-Specific Diet, Metabolic Variability, and Breast Cancer Risk in African-American Women (2003) (0)
Association of ZNF350 Leu66Pro polymorphism and prostate cancer risk in African Americans and Caucasians. (2006) (0)
Abstract 885:GSTM1CNV and promoter SNPs are associated with REC/SPT and survival after Retinoid Acid treatment for head and neck cancer (2010) (0)
Twenty-fourth Annual General Meeting of the British Association for Cancer Research* (incorporating a Symposium on "environmental Carcinogenesis" and the Walter Abstracts of Invited and Proffered Papers Human Monitoring for Carcinogen Exposure Using Chemical Methods Detection and Quantification of S (0)
The SNP rs380390 of complement factor H gene is associated with the risk of lung cancer and interacts with ERCC6 SNP rs3793784 (2008) (0)
Occurrence of 4 aminobiphenyl dna adducts in human lung in relation to metabolic activation pathways (1989) (0)
Association between the UGT1A1 tandem repeat promoter polymorphism and prostate cancer risk. (2006) (0)
Genetic variants of GSTM5, SULT1C2 and CYP39A1 and the risk of breast cancer in Caucasians and African-Americans (2008) (0)
Racial Differences in Motor Neuron Disease (P01.096) (2012) (0)
Abstract A95: Genetic variability in energy metabolism and pancreatic cancer risk: A population-based case-control study in Minnesota (2008) (0)
Hormone-Metabolizing Genotypes: An Alternate Interpretation (2007) (0)
Determination of N-acetyltransferase and cytochrome P4501A2 phenotypes in human populations by analysis of caffeine urinary metabolites: correlation to genotype of N-acetyltransferase. (1993) (0)
Molecules in focus Sulfotransferase 4 A 1 (2008) (0)
Carcinogen-DNA adducts as probes for the mechanisms of chemical mutagenesis and carcinogenesis (1987) (0)
Mechanistic approaches to biochemical toxicology (1982) (0)
Abstract 916: Functional significance of sulfotransferase 1A1 polymorphisms in the 3’ untranslated region in determination of enzymatic activity (2010) (0)
FATTY ACID DEPENDENT-ENZYME STIMULATED ACTIVATION OF CARCINOGENIC ARYLAMINES TO THE DEOXYRIBONUCLEIC ACID BINDING PRODUCTS (1986) (0)
Abstract LB-105: Single nucleotide polymorphisms (SNPs) in the CYP19A1 gene are strongly associated with CYP1A2 expression: First evidence for epistasis in the CYP superfamily (2010) (0)
Hepatic MicrosomalN-Glucuronidation and Nucleic Acid Binding of N-Hydroxy Arylamines in Relation to Urinary Bladder Carcinogenesis 1 (2006) (0)
Effect of 677 C to T mutations in the methylenetetrahydrofolate reductase gene, folate intake and plasma homocysteine on adenoma recurrence (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With F. Frank Kadlubar?

F. Frank Kadlubar is affiliated with the following schools: